跳至主要内容
临床试验/NCT02184273
NCT02184273已完成4 期

Randomized, Double Blind, Comparative Trial of the Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children of 6 and 11 Years Old Undergoing Minor Surgery

Boehringer Ingelheim0 个研究点目标入组 122 人开始时间: 2002年3月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
122
主要终点
Percentage of children requiring rescue medication

研究概览

简要总结

Study to assess the analgesic efficacy in the prevention of postoperative pain in children undergoing minor surgery (herniorraphy, tonsillectomy) and to assess the tolerability of Metamizol in this group of patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
6 Years 至 11 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children of either sex between 6 and 11 years of age
  • Patients undergoing routine inguinal hernia repair or tonsillectomy
  • Written informed consents by the guardian, according to the guidelines of Good Clinical Practice and current legislation
  • The ability of the patient to understand and carry out the visual analogue scale assessments
  • Patients with a physical status American Society of Anesthesiologist I or II class

排除标准

  • The use of any drug with analgesic properties in the 24 hours prior to the administration of the study drug
  • Surgery with a foreseen duration over 60 minutes
  • Patients with a nutritional index of less than 90 or greater than 120
  • Patients with a body mass index which was not between the 3rd centile and the 97th centile for age
  • Patients with any illness or malformation (except hernia) which, in the doctor's opinion, contraindicated the use of metamizol (aplastic anemia, agranulocytosis of a toxicological etiology, severe renal disease, etc.)
  • Patients who have received in the previous 7 days or need currently anticoagulant treatment
  • Significant allergy or known hypersensitivity to metamizol, its excipients and/or to other nonsteroidal antiinflammatory drugs
  • Patients in whom the anesthetic regimen required by the protocol cannot be used
  • Patients who have participated in another clinical trial in the past four weeks or are currently participating in another clinical trial
  • Patients with any psychological disturbance which, in the investigator's opinion makes the patient unsuitable for inclusion in the trial

研究组 & 干预措施

Magnesium metamizol

Experimental

干预措施: Magnesium metamizol (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Percentage of children requiring rescue medication

时间窗: up to 4 hours after drug administration

次要结局

  • Percentage of children who require rescue medication(up to 2 hours after drug administration)
  • Evaluation of the pain intensity by the patient by means of a Visual Analogue Scale (VAS)(up to 4 hours)
  • Time from drug administration, end of surgery and first patient's awake to the administration of rescue medication(up to 4 hours)
  • Evaluation of the pain intensity by the patient by means of a four points Verbal Rating Scale (VRS)(up to 4 hours)
  • Assessment of the state of the patient by the guardian by means of the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) test(up to 4 hours)
  • Assessment of the partial efficacy by the investigator by means of a four points VRS(up to 4 hours)
  • Assessment of the total efficacy by the investigator by means of a four points VRS(after 4 hours)
  • Number of patients with adverse events (AE)(up to 4 hours)
  • Number of withdrawals due to AEs(up to 4 hours)
  • Assessment of the total tolerability of the assigned treatment by the investigator by means of a four points VRS(after 4 hours)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Efficacy and Tolerability of Nolotil i.v. vs.... | 临床试验